Based on World Bank guidelines, hepatitis B immunization would be an excellent public health investment, saving each life year for well below the per-capita gross domestic product. This would be one of the most cost-effective investments India could make in the field of health.
CITATION STYLE
Miller, M. A., & Kane, M. (2000). Routine hepatitis B immunisation in India : Cost-effectiveness assessment. Indian Journal of Pediatrics. The Indian Journal of Pediatrics. https://doi.org/10.1007/BF02758178
Mendeley helps you to discover research relevant for your work.